Vivus (VVUS) to Make Several Qsymia Presentations at 48th EASD

VIVUS, Inc. (Nasdaq: VVUS) announced several Qsymia scientific presentations at the 48th Annual Meeting of European Association for the Study of Diabetes (EASD) currently underway in Messe Süd, Berlin, Germany.

On Wednesday, October 3, 2012, the following posters will be presented:

Poster Number 695 – Arne Astrup, MD, DMSc (Presented by Hermann Toplak, MD)

Jean-Michel Oppert, MS, PhD; Craig A. Peterson, MS

Weight Loss and Improvements in Cardiometabolic Outcomes With Extended-Release Phentermine/Topiramate Treatment in Overweight/Obese Subjects With Type 2 Diabetes

Abstract Number A-12-290-EASD

Poster Number 696 – Stephan Rössner, MD, PhD

Arya M. Sharma, MD, PhD; Barbara Troupin, MD, MBA; Raj Padwal, MD

Effects of Extended-Release Phentermine/Topiramate on Weight Loss and Blood Pressure in Obese Subjects With Type 2 Diabetes Mellitus

Abstract Number A-12-1079-EASD

Poster Number 697 – Jens Jordan, MD

Arne Astrup, MD, DMSc; Wesley W. Day, PhD

Effects of Phentermine and Extended-Release Topiramate Alone and in Combination on Cardiovascular Risk Factors

Abstract Number A-12-993-EASD

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Getty Realty discloses separation terms for departing accounting officer
• James Hardie sells Fermacell unit to Holcim for €840 million
• AEVEX wins $41M U.S. government contract for one-way attack systems